StockData
Axil Brands, Inc. logo

Axil Brands, Inc. (AXIL) company profile

AXILNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 19/3059% below fair value
$4.94−0.05 (-1.00%)

Close on Nov 17, 2026Market cap $33.70MP/E 14.5Yield –

About Axil Brands

Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844

AXIL Brands, Inc. develops, manufactures, markets, and distributes audio and hearing enhancement and protection devices, professional hair and skin care products, and marketing services. Its hearing segment provides earplugs, earmuffs, Bluetooth earbuds, and outdoor speakers for consumers in sporting goods, tactical, industrial, and recreational markets, as well as military personnel and law enforcement. The hair and skin care line offers shampoos, conditioners, scalp treatments, and styling aids under the Reviv3 Procare brand.

The company operates primarily across the United States, with a growing international presence in Canada, Europe, Australia, New Zealand, Asia, and Africa. Its hearing products reach consumers through direct online platforms, dealers, and approximately 6,000 retail stores, including big-box partnerships such as Walmart. Additionally, the business maintains 14 non-exclusive distribution agreements across the United States, Canada, Europe, and Asia for its hair care offerings. AXIL Brands is headquartered in Beverly Hills, California.

Summary of the business section of Axil Brands's latest annual report, written by StockData.

Company profile

Company

Legal name
Axil Brands, Inc.
Headquarters
Beverly Hills, CA
Address
9150 Wilshire Boulevard, Unit 245 90212
Phone
(888) 638-8883
Website
goaxil.com
Employees
13, May 31, 2026
Industry
Perfumes, Cosmetics & Other Toilet Preparations
Incorporated in
Delaware
Fiscal year ends
May 31
Auditor
SALBERG & COMPANY, P.A., Boca Raton, Florida

Stock & identifiers

Ticker
AXIL
Exchange
NYSE
IPO date
Feb 14, 2024
Shares outstanding
7M, Oct 2, 2026
Public float
$20.71M, Nov 28, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-20 reverse, Apr 9, 2024
SEC CIK
1718500
CUSIP
76151R206
ISIN
US76151R2067
FIGI
BBG00HXXP3F3
Share class FIGI
BBG00HXXP3G2
EIN
47-4125218

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jeffrey B. BrownCFO, COO, Director160,143
Manu OhriDirector25,001
Nancy HundtDirector17,273
Thomas PennaDirector23,000
Peter Philip DunneDirector31,250

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026$583.54K$727.91K$540.27K––
FY2025$1.63M$2.30M$1.27M––
FY2024–-$70.83K$330.76K––
FY2023–$512.08K$82.39K––
FY2022$279.00K$728.50K$82.67K––

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryOption awardsOtherTotalvs. prior year
Jeff Toghraie
Chief Executive Officer and Chairman
–$1.40M$227.10K$1.63M–
Jeff Brown
Chief Operating Officer, Chief Financial Officer, and Director
$144.00K$1.00M$120.00K$1.27M+500%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of May 31, 2026, we had thirteen full-time employees and two part-time employees, all of whom were employed in the United States and none employed outside the United States.”

Corporate history

Events identified from SEC filings

DateEventDetails
Feb 13, 2024Name changeName changed from Reviv3 Procare Co to Axil Brands, Inc.
Feb 12, 2024ListingRegistration of securities on an exchange (Form 8-A)
Jun 22, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)

See a number that looks wrong?